Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Rauh-Hain JA"" wg kryterium: Autor


Tytuł :
Management and outcomes for elderly women with vulvar cancer over time.
Autorzy :
RauhHain, JA
Clemmer, J
Clark, RM
Bradford, LS
Growdon, WB
Goodman, A
Boruta, DM
Dizon, DS
Schorge, JO
Carmen, MG
Pokaż więcej
Temat :
VULVAR cancer
SQUAMOUS cell carcinoma
CANCER in women
DISEASES in women
Źródło :
BJOG: An International Journal of Obstetrics & Gynaecology; May2014, Vol. 121 Issue 6, p719-727, 8p, 3 Charts, 1 Graph
Terminy geograficzne :
UNITED States
Czasopismo naukowe
Tytuł :
Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer.
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, the Department of Health Services Research, Division of Cancer Prevention and Population Sciences, and the Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas; the Department of Obstetrics and Gynecology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts; the Department of Obstetrics and Gynecology, the University of Texas Medical Branch at Galveston, Galveston, Texas; and the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, and the Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York.
Clapp MA
Fu S
Lamiman K
Melamed A
Brady PC
Kaimal A
Del Carmen MG
Woodard TL
Meyer LA
Giordano SH
Ramirez PT
Rauh-Hain JA
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2021 Jun 01; Vol. 137 (6), pp. 1109-1118.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003-17.
Autorzy :
Offodile II AC; Anaeze C. Offodile II () is an assistant professor in the Department of Plastic and Reconstructive Surgery, University of Texas MD Anderson Cancer Center, in Austin, Texas, and a nonresident fellow in Domestic Health Policy at the Baker Institute for Public Policy, Rice University, in Houston, Texas. He is the current Gilbert Omenn Fellow of the National Academy of Medicine.
Cerullo M; Marcelo Cerullo is a resident in the General Surgery Residency Program, Duke University Hospital, in Durham, North Carolina.
Bindal M; Mohini Bindal is a research assistant in the Baker Institute for Public Policy, Rice University, and a medical student at Baylor College of Medicine, in Houston, Texas.
Rauh-Hain JA; Jose Alejandro Rauh-Hain is an assistant professor in the Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center.
Ho V; Vivian Ho is the James A. Baker III Institute Chair in Health Economics at Rice University and a professor in the Department of Medicine at Baylor College of Medicine.
Pokaż więcej
Źródło :
Health affairs (Project Hope) [Health Aff (Millwood)] 2021 May; Vol. 40 (5), pp. 719-726.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Delivery of Health Care*
Investments*
Government Programs ; Health Facilities ; Hospitals, Private ; Humans
Czasopismo naukowe
Tytuł :
Facilitated cascade testing (FaCT): a randomized controlled trial.
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Moss HA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
Watson CH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
Urbauer DL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Melamed A; Department of Obstetrics and Gynecology and Herbert Irving Comprehensive Cancer Center, Columbia University, New York Presbyterian Hospital, New York, New York, USA.
Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lipkin SM; Departments of Medicine and Genetic Medicine, Weill Cornell Medicine, New York, New York, USA.
Offit K; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Frey MK; Division of Gynecologic Oncology, Weill Cornell Medicine, New York, New York, USA .
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2021 May; Vol. 31 (5), pp. 779-783. Date of Electronic Publication: 2020 Dec 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer.
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fellman BM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2021 Apr 15. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer.
Autorzy :
Fleming ND; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America. Electronic address: .
Westin SN; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Soliman PT; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Fellman BM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Coleman RL; US Oncology Research, The Woodlands, TX. 77380, United States of America.
Meyer LA; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Shafer A; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Cobb LP; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Jazaeri A; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Lu KH; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Sood AK; Department of Gynecologic Oncology and Reproductive Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States of America.
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2021 Apr 07. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials.
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Melamed A; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States of America.
Gockley AA; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States of America.
Floyd J; Department of Obstetrics and Gynecology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States of America.
Krause KJ; Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Coleman RL; US Oncology Research, The Woodlands, TX, United States of America.
Matulonis UA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America.
Giordano SH; Departments of Health Services Research and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2021 Mar 15. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature.
Autorzy :
Bercow A; Division of Gynecologic Oncology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital (Dr. Bercow); Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital (Dr. Bercow), Boston, Massachusetts.
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center (Drs. Nitecki and Rauh-Hain), Houston, Texas.
Brady PC; Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center (Dr. Brady), New York, New York.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center (Drs. Nitecki and Rauh-Hain), Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
Journal of minimally invasive gynecology [J Minim Invasive Gynecol] 2021 Mar; Vol. 28 (3), pp. 527-536.e1. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
Czasopismo naukowe
Tytuł :
Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes.
Autorzy :
Floyd JL; Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA.
Campbell S; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Baylor College of Medicine, Houston, TX, USA.
Rauh-Hain JA; Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Woodard T; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Baylor College of Medicine, Houston, TX, USA .; Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2021 Mar; Vol. 31 (3), pp. 345-351. Date of Electronic Publication: 2020 Jun 21.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis.
Autorzy :
Rodriguez J; Department of Gynecologic Oncology, Instituto Nacional de Cancerologia, Bogota, Colombia.; Department of Gynecology and Obstetrics, Section of Gynecologic Oncology, Fundacion Santa Fe de Bogota, Bogota, Colombia.
Rauh-Hain JA; Departments of Gynecologic Oncology and Reproductive Medicine and Health Services Research, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Saenz J; Department of Gynecologic Oncology, Instituto Nacional de Cancerologia, Bogota, Colombia.
Isla DO; Department of Gynecologic Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico.
Rendon Pereira GJ; Department of Gynecologic Oncology, Instituto de Cancerologia Las Américas, Medellín, Colombia.
Odetto D; Gynecology Oncology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Martinelli F; Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Villoslada V; Department of Gynecologic Oncology, Instituto Nacional de Enfermedades Neoplasicas (INEN), Lima, Peru.
Zapardiel I; Gynecologic Oncology Unit. La Paz University Hospital, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Trujillo LM; Department of Gynecologic Oncology, Instituto Nacional de Cancerologia, Bogota, Colombia.
Perez M; Department of Gynecologic Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico.
Hernandez M; Department of Gynecologic Oncology, Instituto de Cancerologia Las Américas, Medellín, Colombia.
Saadi JM; Gynecology Oncology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Raspagliesi F; Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Valdivia H; Department of Gynecologic Oncology, Instituto Nacional de Enfermedades Neoplasicas (INEN), Lima, Peru.
Siegrist J; Gynecologic Oncology Unit. La Paz University Hospital, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Fu S; Departments of Gynecologic Oncology and Reproductive Medicine and Health Services Research, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Hernandez Nava M; Department of Gynecologic Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico.
Echeverry L; Department of Gynecologic Oncology, Instituto de Cancerologia Las Américas, Medellín, Colombia.
Noll F; Gynecology Oncology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Ditto A; Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Lopez A; Department of Gynecologic Oncology, Instituto Nacional de Enfermedades Neoplasicas (INEN), Lima, Peru.
Hernandez A; Gynecologic Oncology Unit. La Paz University Hospital, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Pareja R; Department of Gynecologic Oncology, Instituto Nacional de Cancerologia, Bogota, Colombia .; Gynecologic Oncology, Clinica Astorga, Professor Universidad Pontificia Bolivariana, Medellin, Colombia.
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2021 Jan 27. Date of Electronic Publication: 2021 Jan 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Employment disruption following the diagnosis of endometrial cancer.
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Fu S; Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Lefkowits C; Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Department of Internal Medicine, Palliative Care, University of Colorado Denver, Aurora, CO, United States of America.
Smith BD; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, United States of America.
Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Melamed A; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States of America.
Giordano SH; Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2021 Jan; Vol. 160 (1), pp. 199-205. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
Czasopismo naukowe
Tytuł :
Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.
Autorzy :
Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA .
Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Shafer A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Onstad M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cobb L; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bevers M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Fellman BM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Burzawa J; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
Bhosale P; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zand B; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jazaeri A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Levenback C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2021 Jan; Vol. 31 (1), pp. 92-97. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies.
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Woodard T
Rauh-Hain JA
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2020 Dec; Vol. 136 (6), pp. 1157-1169.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Pregnancy Outcome*
Fertility/*physiology
Infertility, Female/*prevention & control
Ovarian Neoplasms/*therapy
Uterine Neoplasms/*therapy
Female ; Humans ; Ovarian Neoplasms/pathology ; Pregnancy ; Pregnancy Complications, Neoplastic ; Randomized Controlled Trials as Topic ; Uterine Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE).
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA .
Melamed A; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Scambia G; Department of Women's and Children's Health, Policlinico A Gemelli, Rome, Italy.; Catholic University Sacred Heart, Rome, Italy.
Pareja R; Instituto Nacional de Cancerología, Bogotá, and Clínica de Oncología Astorga, Medellin, Colombia.
Coleman RL; The US Oncology Network, The Woodlands, Texas, USA.
Ramirez PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Fagotti A; Department of Women's and Children's Health, Policlinico A Gemelli, Rome, Italy.; Catholic University Sacred Heart, Rome, Italy.
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Sep; Vol. 30 (9), pp. 1450-1454. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
Czasopismo naukowe
Tytuł :
Cervical Cancer Screening in Women with Systemic Lupus Erythematosus.
Autorzy :
Bruera S; Department of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, Texas, United States.
Lei X; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Zogala R; Department of Rheumatology, Community Hospital - Grand Valley Rheumatology, Grand Junction, Colorado, United States.
Pundole X; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Zhao H; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Giordano SH; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Hwang JP; Department of General Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States.
Rauh-Hain JA; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Suarez-Almazor ME; Department of Rheumatology, Community Hospital - Grand Valley Rheumatology, Grand Junction, Colorado, United States.
Pokaż więcej
Źródło :
Arthritis care & research [Arthritis Care Res (Hoboken)] 2020 Aug 16. Date of Electronic Publication: 2020 Aug 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
Autorzy :
Dottino JA; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
He W; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sun CC; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zhao H; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Fu S; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Suidan RS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Giordano SH; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA .
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Aug; Vol. 30 (8), pp. 1195-1202. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis.
Autorzy :
Nitecki R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Ramirez PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Frumovitz M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Krause KJ; Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston.
Tergas AI; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Wright JD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Melamed A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2020 Jul 01; Vol. 6 (7), pp. 1019-1027.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Hysterectomy*
Minimally Invasive Surgical Procedures*
Uterine Cervical Neoplasms/*mortality
Uterine Cervical Neoplasms/*surgery
Female ; Humans ; Observational Studies as Topic ; Survival Analysis
Czasopismo naukowe
Tytuł :
Pan-cancer clinical and molecular analysis of racial disparities.
Autorzy :
Lara OD; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Asare A; Baylor College of Medicine, Houston, Texas.
Xu T; Department of Gynecologic Oncology, University of Michigan, Ann Arbor, Michigan.
Chiu HS; Texas Children's Cancer Center, Houston, Texas.
Liu Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sumazin P; Texas Children's Cancer Center, Houston, Texas.
Uppal S; Department of Gynecologic Oncology, University of Michigan, Ann Arbor, Michigan.
Zhang L; Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania.
Rauh-Hain JA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Feb 15; Vol. 126 (4), pp. 800-807. Date of Electronic Publication: 2019 Nov 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Status Disparities*
African Americans/*genetics
Epigenesis, Genetic/*genetics
European Continental Ancestry Group/*genetics
MicroRNAs/*genetics
Neoplasms/*genetics
African Americans/statistics & numerical data ; Aged ; European Continental Ancestry Group/statistics & numerical data ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasms/epidemiology ; Neoplasms/ethnology ; SEER Program/statistics & numerical data ; Survival Analysis ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Financial toxicity: An adverse effect worthy of a black box warning?
Autorzy :
Dottino JA; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Rauh-Hain JA; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2020 Feb; Vol. 156 (2), pp. 263-264.
Typ publikacji :
Editorial; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Drug Labeling*
Drug-Related Side Effects and Adverse Reactions*
Humans ; Iatrogenic Disease ; United States ; United States Food and Drug Administration
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies